A new study has found that drinking before and after diagnosis of breast cancer does not impact survival from the disease.
In fact, a modest survival benefit was found in women who were moderate drinkers before and after diagnosis due to a reduced risk of dying from cardiovascular disease, a major cause of mortality among breast cancer survivors.
Breast Cancer - Prevention and Management with Lifestyle Changes
Lifestyle choices may or may not cause breast cancer but healthy lifestyle changes can open up avenues beyond breast cancer. Good habits will allow one to fight breast cancer and to live with dignity.
Advertisement
"Our findings should be reassuring to women who have breast cancer because their past experience consuming alcohol will not impact their survival after diagnosis," said Polly Newcomb, Ph.D., a member of the Public Health Sciences Division and head of the Cancer Prevention Program at Fred Hutchinson Cancer Research Center, who led the study.
"This study also provides additional support for the beneficial effect of moderate alcohol consumption with respect to cardiovascular disease."
The study was based on data from almost 23,000 women who participated in the Collaborative Breast Cancer Study, a National Cancer Institute-sponsored, multi-site, population-based study of risk factors for breast cancer. The study began in 1988 and was conducted in New Hampshire, Massachusetts and Wisconsin. In a smaller follow-up study between 1998 and 2001, about 5,000 participants were sent a follow-up questionnaire about their alcohol consumption habits after diagnosis.
![Breast Cancer Screening using Mammogram]( "Breast Cancer Screening using Mammogram")
Breast cancer if detected early can be completely cured. Mammography is used to screen women for breast cancer.
Among study participants with a history of breast cancer, the authors found that the amount and type of alcohol a woman reported consuming in the years before her diagnosis was not associated with her likelihood from dying from breast cancer. However, the authors also found that those who consumed a moderate level of alcohol (three to six drinks per week) in the years before their cancer diagnosis were 15 percent less likely to die from cardiovascular disease than non-drinkers. Moderate wine consumption in particular was associated with a lower risk of cardiovascular disease mortality, while no such benefit was evident for consumption of beer or spirits, or for heavier levels of alcohol consumption.
Similar patterns were evident when considering reported alcohol consumption after breast cancer diagnosis. The amount and type of alcohol a woman consumed after diagnosis did not appear to be associated with survival of breast cancer, but those who consumed alcohol in moderation experienced a 39- to 50-percent lower mortality rate from cardiovascular disease.
Newcomb said that the difference in alcohol's impact on developing breast cancer risk and on survival from the disease could be that the kind of breast cancer that is more likely to be diagnosed among women who drink may be more responsive to hormone-reduction therapies.
Alcohol consumption is believed to influence breast cancer risk through increases in estrogen production in both pre- and post-menopausal women.
The study will be published in the Journal of Clinical Oncology.
Source: ANI
The study was based on data from almost 23,000 women who participated in the Collaborative Breast Cancer Study, a National Cancer Institute-sponsored, multi-site, population-based study of risk factors for breast cancer. The study began in 1988 and was conducted in New Hampshire, Massachusetts and Wisconsin. In a smaller follow-up study between 1998 and 2001, about 5,000 participants were sent a follow-up questionnaire about their alcohol consumption habits after diagnosis.
Breast Cancer Screening using Mammogram
Breast cancer if detected early can be completely cured. Mammography is used to screen women for breast cancer.
Advertisement
Among study participants with a history of breast cancer, the authors found that the amount and type of alcohol a woman reported consuming in the years before her diagnosis was not associated with her likelihood from dying from breast cancer. However, the authors also found that those who consumed a moderate level of alcohol (three to six drinks per week) in the years before their cancer diagnosis were 15 percent less likely to die from cardiovascular disease than non-drinkers. Moderate wine consumption in particular was associated with a lower risk of cardiovascular disease mortality, while no such benefit was evident for consumption of beer or spirits, or for heavier levels of alcohol consumption.
Similar patterns were evident when considering reported alcohol consumption after breast cancer diagnosis. The amount and type of alcohol a woman consumed after diagnosis did not appear to be associated with survival of breast cancer, but those who consumed alcohol in moderation experienced a 39- to 50-percent lower mortality rate from cardiovascular disease.
Newcomb said that the difference in alcohol's impact on developing breast cancer risk and on survival from the disease could be that the kind of breast cancer that is more likely to be diagnosed among women who drink may be more responsive to hormone-reduction therapies.
Alcohol consumption is believed to influence breast cancer risk through increases in estrogen production in both pre- and post-menopausal women.
The study will be published in the Journal of Clinical Oncology.
Source: ANI
Breast Cancer Management: Advances
The crab that invades the breast is no more a fear factor with all the advancements that medical science and customized protocols can fight breast cancer. the recent developments in the management of breast cancer.
Advertisement
 Breast Cancer during PregnancyManagement of breast cancer during pregnancy or pregnancy associated breast cancer requires special consideration to avoid harm to the fetus. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
